Results 61 to 70 of about 10,142,751 (308)

From mice to humans—divergent strategies for intestinal homeostasis and regeneration

FEBS Letters, EarlyView.
Recent advances such as organoid genome editing, xenotransplantation, imaging, and whole‐genome sequencing have enabled direct studies of human intestinal stem cells (ISCs). These studies reveal species‐specific features, including slower ISC proliferation, distinct injury responses, slower somatic mutation accumulation in humans, and an inverse ...
Keiko Ishikawa, Shinya Sugimoto, Toshiro Sato   +2 more
wiley   +1 more source

Patient and disease factors associated with disease free survival.

, 2016
(A) Disease Free Survival with Node Stage 0 (0) vs Node Stage 1 (1). (B) Disease Free Survival of histologic Grade utilizing three tier grading (1: well differentiated, 2: intermediate differentiation, poorly differentiated).
Nicholas Nissen (2576413), Quanlin Li (516061), Jason Naziri (2576401), Richard Tuli (1697), Wensha Yang (2576398), Andrew Hendifar (2576410), Arsen Osipov (2576404), Jasleen Khanuja (2576407)   +7 more
core   +1 more source

Structural insights and therapeutic targets in Acinetobacter baumannii capsule biosynthesis

FEBS Letters, EarlyView.
Hypervirulent KL49 A. baumannii's capsular polysaccharide contains the nonulosonic acid 8‐epi‐Leg5,7Ac2, synthesized by epimerization via ElaA, ElaB, and ElaC. Crystal structures of ElaA, ElaB, and ElaC reveal their role in CMP‐Leg5,7Ac2 synthesis and regioselective C8 epimerization.
Woo Cheol Lee, Junho Jeong, Chae Yeong Lee, Hyunjoon Cho, Man Hwan Oh, Je Chul Lee, Jee‐Young Lee, Yangmee Kim   +7 more
wiley   +1 more source

Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictors

Cancer Medicine, 2023
Purpose To clarify the necessity and effect of a single intraoperative instillation of chemotherapy during radical cystectomy. Methods Patients who underwent radical cystectomy for bladder cancer between January 2013 and April 2019 were retrospectively ...
Jingtian Yang, Kaiwen Li, Yishan Zhang, Jintao Hu, Hao Liu, Wen Dong, Hai Huang, Tianxin Lin, Jian Huang, Wang He   +9 more
doaj   +1 more source

Survival Outcomes of Patients with Locally Advanced Breast Cancer after Neoadjuvant Systemic Therapy in St. Luke’s Medical Center

Asian Pacific Journal of Cancer Care, 2023
Background: In locally-advanced breast cancers (LABC), the previous primary goal of neoadjuvant systemic therapy was to improve resectability and achieve better margins.
Cristina G. Domingo, Fritz Lorenz E. Ortega, Mark James Arce, Mel Valerie B. Cruz-Ordinario, Agnes E. Gorospe, Carlos Dy   +5 more
doaj   +1 more source

Disease-free and overall survival analyses according to MMP-9 levels.

, 2018
Disease-free and overall survival analyses according to MMP-9 levels.
Sukjoong Oh (5683670), Seong Sik Bang (5683661), Young Hwan Kim (132717), Sung-Im Do (5683667), Young Ha Oh (5683664), Jungho Yang (5683643), Mi Jung Kwon (5683673), Dong-Hoon Kim (5683649), Seoung Wan Chae (229254), Byoung Kwan Son (5683652), Young Chan Wi (5683658), Kyueng-Whan Min (5683646), Kyoung Min Moon (5683655)   +12 more
core   +1 more source

Decoding the dynamic extracellular matrix in cancer—3D models and bioscaffolds rewire the rules of tumor progression

FEBS Letters, EarlyView.
Cancer progression is regulated by the dynamic matrix code of the tumor microenvironment, which influences cellular behavior and disease development. Importantly, matrix remodeling in three‐dimensional cancer models more accurately reflects in vivo conditions compared to conventional two‐dimensional systems.
Sylvia Mangani, Konstantinos Spanopoulos, Zoi Piperigkou, Nikos K. Karamanos   +3 more
wiley   +1 more source

Prognostic significance of circulating tumor DNA detection and quantification in cervical cancer: a systematic review and meta-analysis

Frontiers in Oncology
BackgroundCirculating tumor DNA (ctDNA) is an emerging biomarker in cervical cancer, with elevated levels typically indicating a higher tumor burden. However, its prognostic value in cervical cancer patients remains debated.
Xiumin Zhao, Shufu Hou, Ruiqi Hao, Yelei Zang, Dandan Song   +4 more
doaj   +1 more source

Disease-free survival according to clinical PET type determined by individual surgeons.

, 2017
Disease-free survival according to clinical PET type determined by individual surgeons.
Ho Kyoung Hwang (3164271), Jin Ho Lee (513073), Jae Uk Chong (3779176), Woo Jung Lee (286501), Chang Moo Kang (3164277), Mijin Yun (806359)   +5 more
core   +1 more source

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients. [PDF]

, 2015
BACKGROUND Cytomegalovirus (CMV) is associated with an increased risk of cardiac allograft vasculopathy (CAV), the major limiting factor for long-term survival after heart transplantation (HTx).
Selimovic, Nedim, Friman, Vanda,, Johansson, Inger, Nasic, S., Sigurdardottir, Vilborg, Friman, Vanda, Salmir Nasic, Johansson, Inger,, Andersson, Rune,, Rune Andersson, Nedim Selimovic, Sigurdardottir, V., Inger Johansson, Lars Hanzen, Vilborg Sigurdardottir, Hanzen, Lars, Nasic, Salmir, Nyström, Ulla, Selimovic, N., Andersson, Rune, Hanzén, Lars,, Ulla Nyström, Vanda Friman, Nystrom, U.   +23 more
core   +3 more sources